Delivery Order SPE2DX22D0049-SPE2D826FA0ER
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $13,143.74 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on July 15, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order was...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $91,278.31 firm fixed price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The contract will be performed at the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,009.28 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on October 2, 2025, with an ultimate completion date of October 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $15,695.78 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 6, 2025, with completion expected by October 7, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The delivery order will be fulfilled from the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $211,138.11 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 2, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price, non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $10,181.21 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The contract was...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,483.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order was placed with no set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $45,084.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $3,419.19 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on May 12, 2025, with completion targeted for May 13, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract requires...
- The Defense Logistics Agency's Medical Supply Chain awarded a $14.8K delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 6, 2025, with final completion scheduled for October 7, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA0ERDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,623.74 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract is performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor for federal medical procurement. Through its comprehensive global pharmaceutical support vehicle, the company supplies a wide range of medical commodities including brand-name and generic medications, vaccines, medical devices, and specialized healthcare products across multiple therapeutic domains to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent capability to meet procurement requirements through open competition, serving customers including the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 10/6/25 |